burgericon
Menü
close_icon

Medical University of Innsbruck – Your Competent Partner for Clinical Trials

The Medical University of Innsbruck is a reliable and experienced partner for conducting clinical trials. To make it easier for you to get in touch with us, you will find the most important information and relevant contact details below.

Clinical Trial Site Agreement

Since July 1, 2024, clinical trials with external sponsors are being negotiated under a single-agreement model. The aim of this new structure is to standardize administrative processes, clearly define responsibilities, and strengthen internal cooperation between all involved institutions.

In the Clinical Trial Site Agreement (contracting parties: Medical University of Innsbruck – Sponsor), all services required for conducting clinical trials are jointly presented and negotiated.

These include in particular:

  • Services provided by the trial site
  • Services of Tirol Kliniken GmbH (hospital operator)
  • ZIMCL (Central Institute for Medical and Chemical Laboratory Diagnostics)
  • Hospital pharmacy (as an annex to the Clinical Trial Site Agreement)
  • Internal cooperation partners (as an annex to the Clinical Trial Site Agreement)

Agreements with the Department of Pathology (Innpath GmbH) must currently still be concluded separately.

For questions regarding the Clinical Trial Site Agreement, please contact:
MUI-Startup@i-med.ac.at

CTIS (Clinical Trials Information System)

For clinical drug trials, a Site Suitability Form from the respective trial site is required as part of the CTIS submission.
Find the relevant documents here

Please send the completed form to: mui-oversight@i-med.ac.at

The following CTIS identification numbers apply to the Medical University of Innsbruck:

The ORG ID of the Medical University of Innsbruck (MUI) is ORG-100007200.
The ORG ID of Tirol Kliniken GmbH (TK) is ORG-1000390925.
MUI as a trial site (address: Anichstrasse 35) has the identifier LOC-100014210.

Page title